Ceribell Point-of-Care EEG enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies

Recently peer-reviewed sub analysis of the SAFER-EEG trial has found that early assessment with Ceribell Point-of-Care EEG is associated with shorter median ICU stays and more patients with better neurological outcomes compared to conventional EEG.

“Ceribell use is associated with shorter stays in the ICU and better functional outcomes, which are extremely impactful benefits to patients and their families.”

- Principal Investigator Masoom J. Desai, M.D., FACNS, Assistant Professor, Department of Neurology at the University of New Mexico School of Medicine.

About Ceribell:

The Ceribell system is a novel, point-of-care EEG platform designed to address the unmet neurodiagnostic needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with a sophisticated AI-powered algorithm, the Ceribell system enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

The Ceribell system is FDA 510(k) cleared for indicating suspected seizure activity and currently utilized in intensive care units and emergency rooms across the U.S. The Ceribell system received two FDA Breakthrough Device Designations in 2022, and in 2023, the latest generation of Ceribell’s AI algorithm (Clarity™) made it the first and only device to receive 510(k) clearance for diagnosing electrographic status epilepticus. Subsequently, the Clarity algorithm received a New Technology Add-on Payment (NTAP) from the Centers for Medicare and Medicaid Services (CMS).

360 N Pastoria Avenue
Sunnyvale, CA 94085

Technical Support: 1.800.763.0183

General Inquiries: 1.800.436.0826

Desai, M., et al. Neurocrit Care. 2024 Jul 9. doi: 10.1007/s12028-024-02039-6. Epub ahead of print. PMID: 38981999

Caution: Device does not substitute for EEG review by a qualified clinician. Before use, review the manual for indications, contraindications, warnings, precautions, potential adverse events and Instructions for Use. Sale requires the order of a physician.